 |
|
| |
|
Contact:
Carmen M. Wagner, Ph.D.
(919) 460-3900
Carmen@bfwagner.com
SCI selected to be part of Governor Easley Work Force Development Task Force
Cary, NC - Thursday, August 21, 2003 - Strategic Compliance International, Inc. (SCI) was selected to join other industry and academia representatives to work with the North Carolina Biotech Center (NCBC) to develop a plan for work force development for the North Carolina Biotech industry. NCBC was charged by Governor Easley to develop a strategic plan for biotechnology development statewide. The plan, which will provide a roadmap for the State's future investments in biotechnology, is to be delivered to the Governor by October 31st, 2003.
The Task Force will work under the leadership of a blue ribbon Steering Committee, co-chaired by former Governors Hunt and Martin. As stated by Dr. Leslie Alexander, President and CEO of the NCBC, "The participation and leadership of these individuals will ensure an outcome that is boldly innovative, strengthens biotechnology statewide, and charts North Carolina's international leadership in this enormously competitive technology." Dr. Alexander is a member of the blue ribbon steering committee.
The group, who is charged with developing a realistic and effective plan to aggressively pursue training, is lead by a team of experts, Kathleen Kennedy, Vice President, Education and Training, from the North Carolina Biotechnology Center, and Larry Keen, Vice President, Economic and Workforce Development, North Carolina Community College System. More information on the task force can be obtained from www.ncbiotech.org.
Dr. Wagner, president of SCI, was selected due to her vast experience in the pharmaceutical industry, and in work force training and developing. Dr. Wagner has had a long-term relationship with the NCBC since the early 90's and is currently a member of the NCBC Steering Committee for Bioprocess and Process Development. Dr. Wagner, who has more than twenty years of industry experience and has held a variety of quality related positions in pharmaceuticals, biotechnology, and vaccines added; "I am honored to be part of such an important project, and to be able to help our Governor consider alternative ideas to train the NC biotech workforce."
About Strategic Compliance International (SCI)
Strategic Compliance International, Inc (SCI) is a provider of quality systems' solutions for pharmaceutical, biotech, medical device and vaccine companies. Our primary goal is to deliver quality and cost-effective solutions to assist organizations with the planning, implementation, and maintenance of worldwide regulatory compliance requirements. Our staff can prepare clients for, and assist clients during audits by FDA and other regulatory agencies. Another area of expertise includes compliance assessment of contract manufacturing and contract laboratory facilities on behalf of clients. This service includes facility auditing, as well as assessment of quality systems, training, laboratory data review, and activities associated with Technology Transfer.
Our affiliation with two locations in Europe allows us to better serve our clients who need to do business in Europe and other parts of the world. Our ability to communicate in Portuguese, French, Spanish and Italian facilitates our involvement with global projects. SCI is located at 2500 Regency Parkway, Cary NC 27511. Phone contact: (919) 460-3900; FAX: 460-4689; e-mail: Carmen@bfwagner.com
About the NCBC
The Biotechnology Center is a private, non-profit corporation founded by the State in 1981 as the nation's first government-sponsored biotechnology center. Initially a part of state government, the Center was reconstituted in 1984 as a private, non-profit corporation, giving it greater flexibility and non-partisan neutrality.
Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business and education statewide. More information can be obtained from www.ncbiotech.org.
|
|
|
|
|
|
|
